Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Jansen

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
Annals of the Rheumatic Diseases|April 12, 2007
The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practiceW Kievit, J Fransen, A J M Oerlemans, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 11, 2018
An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity: Results From a Pragmatic Open-Label TrialAn Tran-Duy, Marjan Ghiti Moghadam, Martijn A H Oude Voshaar, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
Annals of the Rheumatic Diseases|April 12, 2007
The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practiceW Kievit, J Fransen, A J M Oerlemans, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 11, 2018
An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity: Results From a Pragmatic Open-Label TrialAn Tran-Duy, Marjan Ghiti Moghadam, Martijn A H Oude Voshaar, et al.
Pageof 7